Sweat chloride concentration less then 60 meq/l does not exclude the diagnosis of cystic fibrosis (CF): analysis of 6 patients

A. E. Alvarez, A. F. Ribeiro, G. Hessel, C. S. Bertuzzo, J. D. Ribeiro (Campinas, Brazil)

Source: Annual Congress 2002 - Cystic fibrosis: new science, new epidemiology, new problems
Session: Cystic fibrosis: new science, new epidemiology, new problems
Session type: Thematic Poster Session
Number: 2117
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. E. Alvarez, A. F. Ribeiro, G. Hessel, C. S. Bertuzzo, J. D. Ribeiro (Campinas, Brazil). Sweat chloride concentration less then 60 meq/l does not exclude the diagnosis of cystic fibrosis (CF): analysis of 6 patients. Eur Respir J 2002; 20: Suppl. 38, 2117

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013


Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function
Source: Eur Respir J 2011; 37: 1076-1082
Year: 2011



Nasal potential difference (NPD) in cystic fibrosis (CF) and non-CF patients with borderline sweat test
Source: Eur Respir J 2001; 18: Suppl. 33, 215s
Year: 2001

Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

A borderline, or negative sweat test, leads to a diagnostic delay in hypertrypsinaemic cystic fibrosis (CF) infants with mild CFTR mutations
Source: Eur Respir J 2001; 18: Suppl. 33, 124s
Year: 2001

Airway surface pH in subjects with cystic fibrosis
Source: Eur Respir J 2003; 21: 37-42
Year: 2003



Microbiological yield of oropharyngeal swab compared to induced sputum in children with cystic fibrosis (CF) < 5 years of age
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Atypical cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38
Year: 2006

Detection of elevated 2-propanol in breath samples from children with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 309s
Year: 2006

Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011

Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Channelopathies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 150-162
Year: 2011


Is lung function diminished by 3 months of age in infants with cystic fibrosis (CF) diagnosed by newborn screening (NBS)?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010


Multiple breath washout in healthy pre-school children and those with cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002

Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
Source: Breathe, 17 (3) 210088; 10.1183/20734735.0088-2021
Year: 2021



Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma
Source: Eur Respir J 2011; 37: 342
Year: 2011



Prevalence of renal impairment in an adult cystic fibrosis (CF) centre
Source: Eur Respir J 2005; 26: Suppl. 49, 622s
Year: 2005

Potential difference test is valuable in the diagnosis of cystic fibrosis (CF)
Source: Eur Respir J 2004; 24: Suppl. 48, 614s
Year: 2004

Difficulty in diagnosis of patients who have cystic fibrosis like symptoms and borderline sweat test
Source: Eur Respir J 2006; 28: Suppl. 50, 716s
Year: 2006

Serum microRNA levels in paediatric females versus males with cystic fibrosis
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016